SEC Form 4/A · accession 0001621170-15-000009
Immunoclin Corp · IMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
DH Bray
Officer — President, CEO · Director · 10% Owner
Period of report
Nov 1, 2014
Accepted (ET)
Jun 18, 2015 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520047
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 10,000,000 | D | ||
| Common StockF1 | holding | — | — | — | 1,000,000 | I | Held by BHD Holding BV, a company which Dr. Bray has voting and investment control over. | |
| Series A Preferred StockF1 | holding | — | — | — | 370,000 | I | Held by BHD Holding BV, a company which Dr. Bray has voting and investment control over. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options | $1.45 | Nov 1, 2014 | A | 1,000,000 | A | Nov 1, 2014 | Nov 1, 2019 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1The Reporting Person is filing this amendment to correct a typographical error that it has just discovered. This Form incorrectly listed shares owned by BDH Holding BV, where the correct name of the company is BHD Holding BV. No other changes have been made to this Form.